Compare · RMD vs XRAY
RMD vs XRAY
Side-by-side comparison of ResMed Inc. (RMD) and DENTSPLY SIRONA Inc. (XRAY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RMD and XRAY operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $28.44B, about 14.2x XRAY ($2.00B).
- Over the past year, RMD is down 21.9% and XRAY is down 38.3% - RMD leads by 16.4 points.
- XRAY has been more active in the news (16 items in the past 4 weeks vs 6 for RMD).
- Both have 25 recent analyst ratings on file.
- Company
- ResMed Inc.
- DENTSPLY SIRONA Inc.
- Price
- $196.01+0.92%
- $10.01+1.42%
- Market cap
- $28.44B
- $2.00B
- 1M return
- -6.57%
- -10.22%
- 1Y return
- -21.95%
- -38.31%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 1987
- News (4w)
- 6
- 16
- Recent ratings
- 25
- 25
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Latest RMD
- Global General Counsel Rider Michael J covered exercise/tax liability with 269 units of ResMed Common Stock, decreasing direct ownership by 3% to 9,488 units (SEC Form 4) (tax withholding)
- Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
- Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
- SEC Form SD filed by ResMed Inc.
- Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
- Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,037,233 worth of ResMed Common Stock (4,991 units at $207.82) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 3 filed by new insider Bloomer Aaron
- SEC Form 4 filed by Chief Financial Officer Sandercock Brett
- SEC Form 8-K filed by ResMed Inc.
Latest XRAY
- Director Lucier Gregory T received a gift of 38,382 shares, was granted 38,382 shares and gifted 38,382 shares (SEC Form 4)
- Director Zurbay Donald was granted 22,822 shares, increasing direct ownership by 332% to 29,693 units (SEC Form 4)
- Director Vergis Janet S. was granted 22,822 shares, increasing direct ownership by 51% to 67,324 units (SEC Form 4)
- Director Varon Leslie F was granted 22,822 shares, increasing direct ownership by 40% to 80,364 units (SEC Form 4)
- Director Mckeon Brian P was granted 28,887 shares (SEC Form 4)
- Director Mazelsky Jonathan Jay was granted 22,822 shares, increasing direct ownership by 79% to 51,669 units (SEC Form 4)
- Director Hosein Clyde was granted 22,822 shares, increasing direct ownership by 55% to 64,075 units (SEC Form 4)
- Director Holden Betsy D was granted 22,822 shares, increasing direct ownership by 42% to 77,442 units (SEC Form 4)
- Director Gladden Brian T was granted 22,822 shares, increasing direct ownership by 79% to 51,864 units (SEC Form 4)
- Director Forbes James D was granted 28,887 shares, increasing direct ownership by 289% to 38,887 units (SEC Form 4)